Total Endovascular Aortic Arch Re-construction Study(TEARS)

NCT01496833 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-01-01

No results posted yet for this study

Summary

The purpose of this study is to investigate the short to mid term efficacy and safety of a newly-developed branched stent graft in patients who had complex aortic lesions, such as ascending aortic/arch aneurysm, pseudo-aneurysm, Stanford Type A dissection, retrograde Stanford Type B dissection, dissection with primary tear located in the aortic arch, et al.

Conditions

  • Aorta Dissection
  • Aorta Aneurysm

Interventions

DEVICE

Ankura Branched/Fenestrated Stent Graft

Ankura Branched/Fenestrated Stent Graft(Lifetech Scientific Co.,LTD.,Shenzhen, China)

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Jian Yang, MD,PhD · Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

  • Dinghua Yi, M.D., PhD. · Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01496833 on ClinicalTrials.gov